Cargando…
LDL-C goal Attainment Among Patients Newly Diagnosed With Coronary Heart Disease or Diabetes in a Commercial HMO
BACKGROUND: Patients beginning treatment with lipid-modifying drugs should have their serum lipid levels monitored and, if necessary, their drug therapy adjusted to reach and maintain their treatment goals. Patients with coronary heart disease or diabetes are at high risk of coronary events and are...
Autores principales: | Nag, Soma S., Daniel, Gregory W., Bullano, Michael F., Kamal-Bahl, Sachin, Sajjan, Shiva G., Hu, Henry, Alexander, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437400/ https://www.ncbi.nlm.nih.gov/pubmed/17970603 http://dx.doi.org/10.18553/jmcp.2007.13.8.652 |
Ejemplares similares
-
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
por: Foody, JoAnne M, et al.
Publicado: (2013) -
Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
por: Alwhaibi, Monira, et al.
Publicado: (2019) -
S/HMO Versus TEFRA HMO Enrollees: Analysis of Expenditures
por: Dowd, Bryan, et al.
Publicado: (1999) -
Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
por: Kastelein, John J.P., et al.
Publicado: (2017) -
Relationship of Oral Antihyperglycemic (Sulfonylurea or Metformin) Medication Adherence and Hemoglobin A1c Goal Attainment for HMO Patients Enrolled in a Diabetes Disease Management Program
por: Lawerence, David B., et al.
Publicado: (2006)